Global Allergy Diagnostic research

Allergy Diagnostic Comprehensive Study by Type (Drug Allergens, Inhaled Allergens, Food Allergens, Others), Medications (Antihistamines, Decongestants, Corticosteroids, Others), End-User (Academic Research Institutes, Diagnostic Laboratories, Hospitals, Clinic Centres, Others) Players and Region - Global Market Outlook to 2026

Allergy Diagnostic Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Allergy diagnostic is a skin test. Allergy is a hypersensitivity disorder of the immune system. This allergy occurs in your ears, eyes, nose, throat, chest and skin. Different kinds of allergies such as food allergy, skin allergy, dust allergy, allergy to insect stings, drug allergy, and mold allergy.

Market Drivers
  • Expansion of product ranges through M&A
  • Increasing access to healthcare insurance

Market Trend
  • Increasing funding for allergy diagnostic devices

Restraints
  • Loss of consciousness, skin rash, blood in a blood pressure

Opportunities
Opportunities in the diagnostics laboratories, hospital-based laboratories, and academic and research institutes and Rising cases of allergies and an increase in the demand for allergy immunotherapy are expected to growth of the market over the forecast period

Players Covered in the Study are:
Danaher Corporation (United States), Hitachi Chemical Diagnostics (California), HOB Biotech Group Co., Ltd. (China), HYCOR BioMedical, Inc. (United States), Omega Diagnostics Ltd. (United Kingdom), Stallergenes (United Kingdom), Lincoln Diagnostics, Inc. (United States), Siemens Healthcare (Germany), Thermo Fisher Scientific, Inc. (United States), Mayo Clinic (United States) and WebMD (United States)

The Global Allergy Diagnostic market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.

What can be explored with Allergy Diagnostic study:
• Where Allergy Diagnostic industry stands in scaling its end use implementations
• What concrete benefits would result from scaled initiatives by Players
• Where Players should focus their investments cycle
• Key success factors and recommendations for upscaling future growth.
• Target Market / Country and Key Business Segments



Report Objectives / Segmentation Covered

By Type
  • Drug Allergens
  • Inhaled Allergens
  • Food Allergens
  • Others

By Medications
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Others

By End-User
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Clinic Centres
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Expansion of product ranges through M&A
      • 3.2.2. Increasing access to healthcare insurance
    • 3.3. Market Challenges
      • 3.3.1. It can affect your airways, sinuses and nasal passages, skin, and digestive system
    • 3.4. Market Trends
      • 3.4.1. Increasing funding for allergy diagnostic devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Allergy Diagnostic, by Type, Medications , End-User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Allergy Diagnostic (Value)
      • 5.2.1. Global Allergy Diagnostic by: Type (Value)
        • 5.2.1.1. Drug Allergens
        • 5.2.1.2. Inhaled Allergens
        • 5.2.1.3. Food Allergens
        • 5.2.1.4. Others
      • 5.2.2. Global Allergy Diagnostic by: Type (Value)
        • 5.2.2.1. Drug Allergens
        • 5.2.2.2. Inhaled Allergens
        • 5.2.2.3. Food Allergens
        • 5.2.2.4. Others
      • 5.2.3. Global Allergy Diagnostic by: End-User (Value)
        • 5.2.3.1. Academic Research Institutes
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Clinic Centres
        • 5.2.3.5. Others
      • 5.2.4. Global Allergy Diagnostic Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Allergy Diagnostic (Price)
  • 6. Allergy Diagnostic: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hitachi Chemical Diagnostics (California)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. HOB Biotech Group Co., Ltd. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. HYCOR BioMedical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Omega Diagnostics Ltd. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Stallergenes (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lincoln Diagnostics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Siemens Healthcare (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mayo Clinic (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. WebMD (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Allergy Diagnostic Sale, by Type, Medications , End-User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Allergy Diagnostic (Value)
      • 7.2.1. Global Allergy Diagnostic by: Type (Value)
        • 7.2.1.1. Drug Allergens
        • 7.2.1.2. Inhaled Allergens
        • 7.2.1.3. Food Allergens
        • 7.2.1.4. Others
      • 7.2.2. Global Allergy Diagnostic by: Type (Value)
        • 7.2.2.1. Drug Allergens
        • 7.2.2.2. Inhaled Allergens
        • 7.2.2.3. Food Allergens
        • 7.2.2.4. Others
      • 7.2.3. Global Allergy Diagnostic by: End-User (Value)
        • 7.2.3.1. Academic Research Institutes
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Clinic Centres
        • 7.2.3.5. Others
      • 7.2.4. Global Allergy Diagnostic Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Allergy Diagnostic (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Allergy Diagnostic: by Type(USD Million)
  • Table 2. Allergy Diagnostic Drug Allergens , by Region USD Million (2015-2020)
  • Table 3. Allergy Diagnostic Inhaled Allergens , by Region USD Million (2015-2020)
  • Table 4. Allergy Diagnostic Food Allergens , by Region USD Million (2015-2020)
  • Table 5. Allergy Diagnostic Others , by Region USD Million (2015-2020)
  • Table 6. Allergy Diagnostic: by Type(USD Million)
  • Table 7. Allergy Diagnostic Drug Allergens , by Region USD Million (2015-2020)
  • Table 8. Allergy Diagnostic Inhaled Allergens , by Region USD Million (2015-2020)
  • Table 9. Allergy Diagnostic Food Allergens , by Region USD Million (2015-2020)
  • Table 10. Allergy Diagnostic Others , by Region USD Million (2015-2020)
  • Table 11. Allergy Diagnostic: by End-User(USD Million)
  • Table 12. Allergy Diagnostic Academic Research Institutes , by Region USD Million (2015-2020)
  • Table 13. Allergy Diagnostic Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 14. Allergy Diagnostic Hospitals , by Region USD Million (2015-2020)
  • Table 15. Allergy Diagnostic Clinic Centres , by Region USD Million (2015-2020)
  • Table 16. Allergy Diagnostic Others , by Region USD Million (2015-2020)
  • Table 17. South America Allergy Diagnostic, by Country USD Million (2015-2020)
  • Table 18. South America Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 19. South America Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 20. South America Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 21. Brazil Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 22. Brazil Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 23. Brazil Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 24. Argentina Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 25. Argentina Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 26. Argentina Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 27. Rest of South America Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 29. Rest of South America Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 30. Asia Pacific Allergy Diagnostic, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 33. Asia Pacific Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 34. China Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 35. China Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 36. China Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 37. Japan Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 38. Japan Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 39. Japan Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 40. India Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 41. India Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 42. India Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 43. South Korea Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 44. South Korea Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 45. South Korea Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 46. Taiwan Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 47. Taiwan Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 48. Taiwan Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 49. Australia Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 50. Australia Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 51. Australia Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 55. Europe Allergy Diagnostic, by Country USD Million (2015-2020)
  • Table 56. Europe Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 57. Europe Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 58. Europe Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 59. Germany Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 60. Germany Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 61. Germany Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 62. France Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 63. France Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 64. France Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 65. Italy Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 66. Italy Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 67. Italy Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 68. United Kingdom Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 69. United Kingdom Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 70. United Kingdom Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 71. Netherlands Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 72. Netherlands Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 73. Netherlands Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 74. Rest of Europe Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 75. Rest of Europe Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 76. Rest of Europe Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 77. MEA Allergy Diagnostic, by Country USD Million (2015-2020)
  • Table 78. MEA Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 79. MEA Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 80. MEA Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 81. Middle East Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 82. Middle East Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 83. Middle East Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 84. Africa Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 85. Africa Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 86. Africa Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 87. North America Allergy Diagnostic, by Country USD Million (2015-2020)
  • Table 88. North America Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 89. North America Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 90. North America Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 91. United States Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 92. United States Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 93. United States Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 94. Canada Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 95. Canada Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 96. Canada Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 97. Mexico Allergy Diagnostic, by Type USD Million (2015-2020)
  • Table 98. Mexico Allergy Diagnostic, by Medications USD Million (2015-2020)
  • Table 99. Mexico Allergy Diagnostic, by End-User USD Million (2015-2020)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Allergy Diagnostic: by Type(USD Million)
  • Table 112. Allergy Diagnostic Drug Allergens , by Region USD Million (2021-2026)
  • Table 113. Allergy Diagnostic Inhaled Allergens , by Region USD Million (2021-2026)
  • Table 114. Allergy Diagnostic Food Allergens , by Region USD Million (2021-2026)
  • Table 115. Allergy Diagnostic Others , by Region USD Million (2021-2026)
  • Table 116. Allergy Diagnostic: by Type(USD Million)
  • Table 117. Allergy Diagnostic Drug Allergens , by Region USD Million (2021-2026)
  • Table 118. Allergy Diagnostic Inhaled Allergens , by Region USD Million (2021-2026)
  • Table 119. Allergy Diagnostic Food Allergens , by Region USD Million (2021-2026)
  • Table 120. Allergy Diagnostic Others , by Region USD Million (2021-2026)
  • Table 121. Allergy Diagnostic: by End-User(USD Million)
  • Table 122. Allergy Diagnostic Academic Research Institutes , by Region USD Million (2021-2026)
  • Table 123. Allergy Diagnostic Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 124. Allergy Diagnostic Hospitals , by Region USD Million (2021-2026)
  • Table 125. Allergy Diagnostic Clinic Centres , by Region USD Million (2021-2026)
  • Table 126. Allergy Diagnostic Others , by Region USD Million (2021-2026)
  • Table 127. South America Allergy Diagnostic, by Country USD Million (2021-2026)
  • Table 128. South America Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 129. South America Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 130. South America Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 131. Brazil Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 132. Brazil Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 133. Brazil Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 134. Argentina Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 135. Argentina Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 136. Argentina Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 137. Rest of South America Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 138. Rest of South America Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 139. Rest of South America Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 140. Asia Pacific Allergy Diagnostic, by Country USD Million (2021-2026)
  • Table 141. Asia Pacific Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 142. Asia Pacific Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 143. Asia Pacific Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 144. China Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 145. China Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 146. China Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 147. Japan Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 148. Japan Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 149. Japan Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 150. India Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 151. India Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 152. India Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 153. South Korea Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 154. South Korea Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 155. South Korea Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 156. Taiwan Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 157. Taiwan Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 158. Taiwan Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 159. Australia Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 160. Australia Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 161. Australia Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 165. Europe Allergy Diagnostic, by Country USD Million (2021-2026)
  • Table 166. Europe Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 167. Europe Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 168. Europe Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 169. Germany Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 170. Germany Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 171. Germany Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 172. France Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 173. France Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 174. France Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 175. Italy Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 176. Italy Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 177. Italy Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 178. United Kingdom Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 179. United Kingdom Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 180. United Kingdom Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 181. Netherlands Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 182. Netherlands Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 183. Netherlands Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 184. Rest of Europe Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 185. Rest of Europe Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 186. Rest of Europe Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 187. MEA Allergy Diagnostic, by Country USD Million (2021-2026)
  • Table 188. MEA Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 189. MEA Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 190. MEA Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 191. Middle East Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 192. Middle East Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 193. Middle East Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 194. Africa Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 195. Africa Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 196. Africa Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 197. North America Allergy Diagnostic, by Country USD Million (2021-2026)
  • Table 198. North America Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 199. North America Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 200. North America Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 201. United States Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 202. United States Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 203. United States Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 204. Canada Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 205. Canada Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 206. Canada Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 207. Mexico Allergy Diagnostic, by Type USD Million (2021-2026)
  • Table 208. Mexico Allergy Diagnostic, by Medications USD Million (2021-2026)
  • Table 209. Mexico Allergy Diagnostic, by End-User USD Million (2021-2026)
  • Table 210. Research Programs/Design for This Report
  • Table 211. Key Data Information from Secondary Sources
  • Table 212. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Allergy Diagnostic: by Type USD Million (2015-2020)
  • Figure 5. Global Allergy Diagnostic: by Type USD Million (2015-2020)
  • Figure 6. Global Allergy Diagnostic: by End-User USD Million (2015-2020)
  • Figure 7. South America Allergy Diagnostic Share (%), by Country
  • Figure 8. Asia Pacific Allergy Diagnostic Share (%), by Country
  • Figure 9. Europe Allergy Diagnostic Share (%), by Country
  • Figure 10. MEA Allergy Diagnostic Share (%), by Country
  • Figure 11. North America Allergy Diagnostic Share (%), by Country
  • Figure 12. Global Allergy Diagnostic share by Players 2020 (%)
  • Figure 13. Global Allergy Diagnostic share by Players (Top 3) 2020(%)
  • Figure 14. Global Allergy Diagnostic share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 18. Hitachi Chemical Diagnostics (California) Revenue, Net Income and Gross profit
  • Figure 19. Hitachi Chemical Diagnostics (California) Revenue: by Geography 2020
  • Figure 20. HOB Biotech Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 21. HOB Biotech Group Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 22. HYCOR BioMedical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. HYCOR BioMedical, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Omega Diagnostics Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Omega Diagnostics Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 26. Stallergenes (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Stallergenes (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Lincoln Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Lincoln Diagnostics, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Siemens Healthcare (Germany) Revenue: by Geography 2020
  • Figure 32. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Mayo Clinic (United States) Revenue, Net Income and Gross profit
  • Figure 35. Mayo Clinic (United States) Revenue: by Geography 2020
  • Figure 36. WebMD (United States) Revenue, Net Income and Gross profit
  • Figure 37. WebMD (United States) Revenue: by Geography 2020
  • Figure 38. Global Allergy Diagnostic: by Type USD Million (2021-2026)
  • Figure 39. Global Allergy Diagnostic: by Type USD Million (2021-2026)
  • Figure 40. Global Allergy Diagnostic: by End-User USD Million (2021-2026)
  • Figure 41. South America Allergy Diagnostic Share (%), by Country
  • Figure 42. Asia Pacific Allergy Diagnostic Share (%), by Country
  • Figure 43. Europe Allergy Diagnostic Share (%), by Country
  • Figure 44. MEA Allergy Diagnostic Share (%), by Country
  • Figure 45. North America Allergy Diagnostic Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Hitachi Chemical Diagnostics (California)
  • HOB Biotech Group Co., Ltd. (China)
  • HYCOR BioMedical, Inc. (United States)
  • Omega Diagnostics Ltd. (United Kingdom)
  • Stallergenes (United Kingdom)
  • Lincoln Diagnostics, Inc. (United States)
  • Siemens Healthcare (Germany)
  • Thermo Fisher Scientific, Inc. (United States)
  • Mayo Clinic (United States)
  • WebMD (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 234 Pages 60 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Allergy Diagnostic research Quantitative research analysis
Global Allergy Diagnostic research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Allergy Diagnostic market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Allergy Diagnostic market are Danaher Corporation (United States), Hitachi Chemical Diagnostics (California), HOB Biotech Group Co., Ltd. (China), HYCOR BioMedical, Inc. (United States), Omega Diagnostics Ltd. (United Kingdom), Stallergenes (United Kingdom), Lincoln Diagnostics, Inc. (United States), Siemens Healthcare (Germany), Thermo Fisher Scientific, Inc. (United States), Mayo Clinic (United States) and WebMD (United States), to name a few.
"Increasing funding for allergy diagnostic devices" is seen as one of major influencing trends for Allergy Diagnostic Market during projected period 2020-2026.

Know More About Global Allergy Diagnostic research Report?

Have a Query? Click Here

Other Related Reports

Injectable Drug Delivery Comprehensive Study by Type (Devices, Conventional Injection Device {Prefilled Syringes and Fillable Syringes}, Self-injection Devices {Needle-Free Injectors (NFI), Wearable ...
$ 3750
Anthrax Vaccines Comprehensive Study by Type (Live Vaccines, Cell free PA Vaccines), Application (Human Use, Animal Use), Disease Type (Cutaneous Anthrax, Gastrointestinal Anthrax, Inhalation Anthrax...
$ 3450
Fibrin Glue Comprehensive Study by Type (Hemostat, Adhesive, Sealant), Application (Hemostasis, Sealing, Tissue Gluing, Support for Wound Healing, Arein cardiac surgery, Burn to bleed, Pulmonary su...
$ 3450
Lignocaine Comprehensive Study by Application (Local Anesthesia, Dentistry, Cardiac Arrhythmia, Epilepsy, Cosmetics, Anti-Arrhythmic, Others), Formulations (Injections, Creams, Ointments, Gels, Aeros...
$ 3450
Pediatric Medicines Comprehensive Study by Application (Hospital, Clinic), Forms (Capsule, Liquid, Ointment, Powder), Diseases (Anemia, Chickenpox, Fever, Asthma, Others), Distribution Channel (Onli...
$ 3800
Anesthesia Masks Comprehensive Study by Type (Oral {Reusable Anesthesia Face Mask and Disposable Anesthesia Face Mask}, Nasopharyngeal {Reusable Anesthesia Face Mask and Disposable Anesthesia Face Ma...
$ 3650